当前位置: 首页 >> 检索结果
2161. COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
作者: Ameet Sarpatwari.;Ankur Pandya.;Emily P Hyle.;Govind Persad.
来源: Ann Intern Med. 2022年175卷2期280-282页
In this commentary, the authors discuss the potential benefits and harms of boosters in response to a boosters-for-all policy for Americans, as well as provide 3 plausible alternative strategies.
2163. A Primary Care-Based Cognitive Behavioral Therapy Intervention for Long-Term Opioid Users With Chronic Pain : A Randomized Pragmatic Trial.
作者: Lynn DeBar.;Meghan Mayhew.;Lindsay Benes.;Allison Bonifay.;Richard A Deyo.;Charles R Elder.;Francis J Keefe.;Michael C Leo.;Carmit McMullen.;Ashli Owen-Smith.;David H Smith.;Connie M Trinacty.;William M Vollmer.
来源: Ann Intern Med. 2022年175卷1期46-55页
Chronic pain is common, disabling, and costly. Few clinical trials have examined cognitive behavioral therapy (CBT) interventions embedded in primary care settings to improve chronic pain among those receiving long-term opioid therapy.
2164. Update on and Future Directions for Use of Anti-SARS-CoV-2 Antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19.
作者: César Boggiano.;Robert W Eisinger.;Andrea M Lerner.;James M Anderson.;Janet Woodcock.;Anthony S Fauci.;Francis S Collins.
来源: Ann Intern Med. 2022年175卷1期119-126页
As the fourth wave of the SARS-CoV-2 pandemic encircles the globe, there remains an urgent challenge to identify safe and effective treatment and prevention strategies that can be implemented in a range of health care and clinical settings. Substantial advances have been made in the use of anti-SARS-CoV-2 antibodies to mitigate the morbidity and mortality associated with COVID-19. On 15 June 2021, the National Institutes of Health, in collaboration with the U.S. Food and Drug Administration, convened a virtual summit to summarize existing knowledge on anti-SARS-CoV-2 antibodies and to identify key unanswered scientific questions to further catalyze the clinical development and implementation of antibodies.
|